Drug
tislelizumab-jsgr
Marketed as TEVIMBRA.
Generic name
tislelizumab-jsgr
Brand names
TEVIMBRA
First FDA approval
2024-03-13
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761232 | TEVIMBRA | 2024-03-13 | BEIGENE |
Manufacturers
BEIGENE
Frequently asked questions
When was tislelizumab-jsgr FDA approved?
Earliest FDA approval on record: 2024-03-13.
What brand names are sold as tislelizumab-jsgr?
TEVIMBRA.
Sources
Appeal a tislelizumab-jsgr denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com